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Candida albicans is common diploid yeast that can be found in the 
gastrointestinal tracts of most human beings. (1) It is an opportunistic yeast pathogen 
that may exist in three forms. Other than the mitochondrial DNA there have been no 
plasmids found in Candida. Since C. albicans is a diploid species, it has a greater 
potential for genetic diversity. In fact, scientists hypothesize that because C. albicans 
does not undergo meiosis, its diploidy, heterozygosity, mitotic recombination, and 
phenotypic instability, might be its tools to help maintain genetic diversity. (5) Because 
of its ability to attack the body, scientists strive to find a treatment that is both safe and 
efficient. Beyond pathogenicity, yeasts are significantly important because of their 
ability to perform as model organisms in the study of genetics. Many genetic problems 
have been solved through working with yeast mainly because of the ease in which 
scientists can culture them, their defined life cycles, and the speed in which generations 
arise from one another. (3) In fact, much of the progress that has been made thus far in 
the regulation of eukaryotic gene expression is because of yeast. (4) Therefore, as 
studies in yeast increase, the ability of scientists to study eukaryotic organisms increases 
as well. Both the genetics and molecular biological studies of C. albicans have 
increased within the last 10 years. Because of this increase, there is a significant amount 
of knowledge gained about the genome and the genetic map of C. albicans. (5) 
Candida albicans generally receives more attention than the other Candida 
species because of its ability to be a human pathogen. C. albicans is considered an 
imperfect yeast. (5) It is a part of the normal flora of the gastrointestinal tract and oral 
cavity. Normally, C. albicans can be found in 80% of humans with no dire effects. 
When the body undergoes slight changes (i.e. temperature, or pH) the unicellular yeast 
form of C. albicans, changes to the multicellular filamentous form. This is called 
Candidiasis and occurs as the common infections; yeast infection, oral thrush, and diaper 
rash. (1) It is when the body's immune system is under stress; as it is in AIDS/HIV 
patients, chemotherapy patients, transplant patients, that Candida can become a serious 
medical issue. In some studies, it has even been found that one-third of the cancer 
patient's after-death autopsies had evidence of C. albicans infections. The common 
vaginal infection accounts for much of the morbidity in women of childbearing age. One 
of the most frequently seen infections in immunocompromised systems is Candida 
esophagitis. 
Scientists are considering two factors that may be important in the pathogenesis of 
C. albicans', it's capability to morph from yeast to hyphal phase, and its differences in 
colony morphology, cell shape, cell surface and cell permeability. (5) Unfortunately, 
unlike the bacteria, yeasts do not yet have proven virulence factors. However, science is 
suggesting that some of the major factors which contribute to the virulence of Candida 
are its ability to form hyphae, its ability to resist phagocytosis, its ability to adhere to 
epithelial cell surfaces, its ability to grow well at 37 degrees Celsius, and its ability to 
secrete acid proteinase. (5) Recent studies are looking into an iC3b receptor that may 
also influence virulence. (5) Unfortunately, factors like nutritional requirements 
complicate the virulence determinations. (3) Molecular Koch's postulates are now being 
considered as a way to study virulence in yeasts. (3) Because of the many problems that 
arise with C. albicans, scientists are taking steps to increase the development of its 
genetics. (5) 
Much of the treatments offered for Candida infections are those that fight off the 
common problems caused by slight changes in the body. C. albicans has been found to 
be naturally resistant to many of the antibiotics that scientists have tried to use against it. 
However, some of the additional antibiotics that are considered unsuitable for treatment 
against infection, have worked in a laboratory setting. C. albicans have been found to be 
sensitive to mycophenolic acid. (5) Nystatin and amphotericin B make treated C. 
albicans cells more permeable to small molecules. Both of these are widely used in the 
treatment of surface and systemic infections. (5) Some of the most effective treatments 
are those that target the cytochrome P450 system. This system is necessary for 
demethylation among the sterol pathways. These treatments include: miconazole, 
ketaconazole, fluconazole, itraconazole, and SCH39304. (5) Some of these treatments 
can be found at general department stores. 
Many of the treatments for C. albicans, including some of those above, are 
considerably harmful for the human body. The treatments are considered fungistatic, 
meaning that they lessen the fungus in question, but do not kill it. These treatments, 
however, do not just lessen the effects of the C. albicans, but any of the natural flora 
within the body; much of which is necessary for homeostasis. The azoles spoken of 
above, are becoming less useful because of their widespread use, and the ability of C. 
albicans to form a resistance because of this. Some of the other treatments even result in 
deleterious side effects. Because of this, treatment for C. albicans is in high demand. It 
is necessary that scientists search for new drug targets. Unfortunately many the proteins 
and metabolic pathways used with the current drugs, are shared by humans. Scientists 
must identify products unique to C. albicans pathogenesis. 
In order to do this, exploratory research is necessary. Using gene reporter systems, we 
can analyze particular genes by studying their promoters. The objective of my study was to 
analyze the CYC1 Promoter using the Renilla luciferase reporter system. CYC1, cytochrome c, 
isoform 1, is an electron carrier in cellular respiration. In oxidative phosphorylation, 
CYCI carries electrons from the cytochrome bcl complex to cytochrome oxidase. (5) 
The CCAAT binding factor is responsible for activating many of the genes that are used 
in respiratory metabolism. 
In hopes of finding the significance of the CYCI promoter regulatory elements in 
Candida albicans we have created six sequential deletions of the CYCI promoter to 
morph that allows it to infect humans. (5) (Five of these deletions were created by a 
previous undergraduate. One of them was created using the oligonucleotides listed in the 
table below.) Each deletion is placed in a plasmid that contains the Renilla luciferase 
gene, from Renilla reniformis, the sea pansy. Using the Renilla luciferase system we are 
able to detect the expression of the CYCI promoter. If the desired promoter is present 
and effective, a bioluminescence is detected. 
This study is limited in that, unfortunately, scientists do not know C. albicans to a 
great extent. Exploratory research is necessary just to understand the workings of C. 
albicans', meaning that treatment may not be found until a considerable time in the future. 
Chapter 2 
Review of the Literature 
Methods of Research 
Research of C. albicans is an important endeavor that is necessary so that 
scientists can gain knowledge of its genetics. With this knowledge, proper treatment can 
be created. Genomics itself is the reason that there are complete or partial genomes for 
fungi, which allows for deeper research. (3) Because of the progression of genetics, 
many of C. albicans characteristics have become known. It has also given scientists the 
opportunity to look back at old information and reinterpret it. (5) Some of the tools most 
often used to study pathogenic fungi are gene isolation, gene expression analysis, and 
gene disruption. (3) In these processes, transformation, hybridization, identification, 
PCR amplification, Northern blotting, and microarrays are all processes used. 
Transformation, the ability to introduce new genetic material into an organism 
was a very important step in C. albicans genetics. It occurred in 1986 and utilizes the 
lithium acetate method to promote the uptake of DNA. C. albicans can also undergo 
electroporation to transform genetic information. (3) 
Electrophoretic Karyotyping allows scientists to examine the chromosomes of an 
organism. C. albicans was one of the first species to be examined by pulse field 
electrophoreses. This process provided the knowledge that C. albicans chromosomes are 
slightly larger than it's "cousins," Saccharomyces cerevisiae. (5) 
Another important ability concerning genetic methods is that to disrupt or delete 
genes. It allows the scientist to study the function of these deleted areas. Selectable 
markers are inserted into the gene and a disruptive mutant is formed. (3) 
The cloning of C. albicans genes can occur by way of complementation, sequence 
homology, and C. albicans ability to confer new sequences on S. cerevisiae strains. The 
first gene isolated by complementation was URA3. (5) 
Microarray technology is now available because of the genome-sequencing 
project. A great advantage to this is identification of patterns involving multiple genes. 
Regulatory genes are a main target in this study. (3) 
Molecular epidemiology and taxonomy for Candida species can be achieved 
through many methods. One of them is to exam the fluorescence of the sample after a 
restriction enzyme cleavage with EcoRI. By looking at the background sequence of 
bands allows the scientist to distinguish which Candida species they are dealing with. 
Specifically in C. albicans, it can allow the scientist to distinguish between C. albicans 
isolates in an infected person. (5) 
Also physical mapping methods are allowing for a genetic map to be created for 
C. albicans. (5) All of these methods and the new ones arising are allowing for greater 
knowledge of C. albicans. Equally important is the opportunity for scientists to compare 
C. albicans with S. cerevisiae and gain more knowledge of its workings. 
Saccharontyces cerevisiae Comparison Methods 
Saccharomyces cerevisiae is another common yeast that scientists know much about. 5. 
cerevisiae is considered a model organism because of the ease that scientists can grow and 
manipulate it. (4) Its similarities to C. albicans have allowed us to make much progress. 
(2) Because S. cerevisiae and Candida albicans diverged nearly 300 million years ago, the 
knowledge that scientists have gained of S. cerevisiae cannot be directly applied to C. albicans. 
S. cervisiae is an avirulent facultative anaerobe that has two forms: the round yeast form, 
of the pseudohyphal form. C. albicans is a pathogenic obligate aerobe that may live in 
three forms: the round yeast form, the pseudohyphal form and the true hyphal form. (2) 
Because there are still some similarities, 5. cerevisiae is used to make comparisons when 
attempting to learn more of C. albicans. Most of C. albicans' cloned genes were isolated 
through their counterparts in S. cerevisiae. (5) Some scientists consider that the beginning of 
molecular genetics of fungi was the genetic transformation of S. cerevisiae in 1977. Since then, 
transformation methods have increased considerably. (3) The DNA transformation system that 
was developed for C. albicans is similar to that of S. cerevisiae. In fact, its development was 
possible because of the availability of corresponding genes previously cloned through S. 
cerevisiae. (5) S. cerevisiae is one of the reasons that such progress has been made with C. 
albicans, and it is also a model to be considered. For example, before DNA arrays were possible 
with C. albicans, S. cerevisiae microarrays were used to prove that C. albicans cells induce the 
principal enzymes MLS1 and ICL1. (3) 
Saccharomyces cerevisiae: The Dual Luciferase system 
An important system, the dual luciferase system is a reporter system that allows 
for the quantification of gene expression. (4) In the past, dual reporters have improved the 
accuracy of transient-reporter assays in mammalian cells. This specific dual luciferase 
system uses the luminescence of the firefly (Photinus pyralis) and sea pansy (Renilla 
reniformis) luciferase proteins. (4) Because both of them are used, it allows for 
measurement of both luciferase activities separately in a single protein extract. Firefly 
and pansy luciferase systems are efficient because of their sensitive, easy, rapid and 
reproducible assays. (4) This is beneficial in that the sensitivity allows the reporter to be 
integrated into the genome and provide measurable signals. The control provides a 
control for experimental variation, like that which can happen in pipetting errors, or cell 
lysis efficiency. Also, because of the controlled assay system, many assays can be 
performed at the same time. (4) The reporter system is efficient and requires only one 
minute to complete each assay. The data yielded accurately reflects the promoter 
activity. (4) Considering that promoters are an integral part of the gene and the gene 
processes, this reporter assay is a significant step forward. 
Creation of a Luciferase System for Candida albicans 
Considering the success of the dual luciferase system, it is unfortunate that it 
cannot work for C. albicans. However, a highly sensitive bioluminescent reporter system 
exists for this purpose. In hopes of functionally characterizing C. albicans promoters, 
this system was created. In the beginning the firefly luciferase gene was used for C. 
albicans as well. However, when scientists noticed a lack of a detectable translation 
product in certain areas, they came to the realization that this method was not sufficient. 
(6) Candida albicans has adopted an unusual codon strategy where it uses a tRNA with a 
CAG anticodon to decode the codon CUG as serine, rather than leucine as most other 
organisms do. (6) Because the firefly luciferase contains 9 in-frame CUG codons, the 
luciferase system does not function as it should. (6) Scientists then studied the CUG 
contents of other biolumiscent reporters until they came upon the one that could 
efficiently analyze promoter action. By using the luciferase gene from Renilla 
Reniformis, the sea pansy, which contains no CUG codons in its reading frame, the 
problem is solved. This reporter system can be used to detect the strength and 
developmental regulation of promoters. This system also has the ability to measure gene 
expression. (6) 
The CCAAT-Binding Factor in Candida albicans 
In Saccharomyces cerevisiae the CCAAT-binding factor is an integral 
transcription activator that stimulates the expression of genes that encode for proteins 
necessary in respiration. (2) Because of its importance in S. cerevisiae, scientists hope to 
discover that if it plays a similar in C. albicans. With exploratory research such as this, 
knowledge of the organism grows and the possibility for treatment is nearer. Because of 
the differences between the two species, scientists cannot guarantee that the CCAAT 
binding factor has maintained the same function or even the same import between the 
organisms. C. albicans, is generally a pathogen, surviving upon a warm-blooded host. S. 
cerevisiae can be found on sugary, fresh or decaying fruits. (2) S. cerevisiae is a 
respirofermentative yeast that gets its energy through fermentation, whether in the 
presence of oxygen or not. (2) C. albicans gets its energy through respiratory metabolism 
when in the presence of oxygen, although it can survive without oxygen. Research 
proved that CCAAT-binding factor was important in the repression of COX 5 and CYC1 
promoters. (2) More research is necessary to detect precisely how, however scientists 
now have reason to believe that the CCAAT-binding factor is important even in 
facultative anaerobe. They also know that although the CCAAT binding factor is a 
necessity in S. cerevisiae, it does not necessitate that it be the same in C. albicans. 
Chapter 3 
Methodology 
• Oligonucleotides: The sequential deletions of the CYC1 promoter region used 
pDM659 (CTC7/505-504) as the template. The 5' primer used was oDM505 
while the 3' primers used were oDM0512, oDM0513, oDM0514, oDM0515, 
oDM0520, and oDM0521. While the oDM505 provided the unique BAMHI site, 
the successive 3' primers added a unique Hindlll site. A PCR reaction was 
performed for pdM659(C7C//505-521) using the program : 1. 95°C for 2 
minutes; 2. 95°C for 1 minutes; 3. 48°C for 1 minute; 4. 62°C for 3 minutes; 5. 




ODM505 5' -ggccaagctttgtaatgatatgtatatagattaaattaaattaaattaaattgg-3 
oDM521 5 '-ggccggatgccgcttggacgtattcccaaatgtacac-3' 
Plasmid Construction: The plasmid pDM659 was digested with the enzymes 
BamH I and Hind III, resolved by agarose gel electrophoresis and purified using 
the GeneClean Kit BIO 101, according to the manufacturer's instructions. The 
plasmid pDM659 was then ligated, with the six PCR products, successively, using 
T4 DNA ligase under standard conditions. They were then introduced to 
CanC1D competent E. coli DH5alpha by transformation. Transformants 
containing the correct plasmids were identified by alkaline lysis mini-preparations 
of the DNA, restriction enzyme digestion, and agarose gel electrophoresis. 
Full length CYC1 Promoter 
pDM659 (CYC1/505-521) 
pDM659 (CYC 1/505-512) 
pDM659 (CYC1/505-513) 
PDM659 (CYC 1/505-515) 
pDM659 (CYC1/505-520) 












• Construction of luciferase reporter yeast strains: All yeast transformations were 
performed using the lithium acetate transformation protocol. The created 
plasmids were linearized with Nrul. The linearized plasmids were subsequently 
introduced to the BWP17pDM596 strain and were selected on medium lacking 
histidine. Upon completing the transformation of pDM659 (CTC7/505-512) into 
Candida albicans, independent colonies were chosen and assayed for Renilla 
luciferase activity. 
• Renilla luciferase assay: Renilla luciferase assays were performed with the 
Renilla luciferase reporter assay system, Promega Corp., Madison, WI. The 
reagents were prepared according to the manufacturer's instructions. The cells 
were grown to exponential phase in appropriate media at 30°C. The cells were 
quantified using a spectrophotometer and lmL of cells was pelleted in a 
centrifuge for 1 minute. After discarding the supernatant, lOOpL of IX passive 
lysis buffer was added to resuspend the cells before adding approximately 1 OOpL 
of sterile glass beads. The sample was vortexed for 1 minute, placed on ice for 30 
seconds, and vortexed again for 1 minute. lOpL of the sample was placed in a 
sample tube and lOOpL aliquot of the substrate was added. Using the Turner 
Designs model TD-20/20 luminometer, the luminescence was measured. The 
Renilla luciferase activity was measured using the formula: 
RLU RLA = 
odJ-̂ S 
Vb 
-Where: RLA-Renilla luciferase activity; RLU-Renilla luciferase luminescence reading; 
OD-optical density A600nm; Va-volume of sample placed in luminometer tube, 0.0 lmL; 
Vb-volume of lysis buffer, 0.1 mL; Vc-volume of cells taken from original culture, lmL. 
Agarose gel electrophoresis: DNA samples were analyzed on .8-1% agarose gel, 
containing 1XTAE according to standard procedures. The DNA samples were loaded 
with 6X loading dye and lkbDNA ladder (Promega) was the standard. 
Figure 2: the plasmid used: pDM659: 
Pvttl - 42" 1 [1J - CG AT'CG 
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Chapter 4 
Analysis of Results 
Plasmid construction results: I was able to successfully create seven plasmids. These 
plasmids contained the full length CYC1 Promoter and truncated portions of it, each 
smaller than the first, successively. 
Transformation results: I was unable to transform plasmids: pDM(0521), pDM(0520), 
pDM(0515), pDM(014), pDM(0513). I was successful in transforming plasmid 
pDM(0512). 
Renilla Luciferase results: I was successful in testing the yeast with the pDM(0512) 
transformant. 
ciferase Activity of Full Length CYC1 Promoter 
in YNBaa pH 5.6 with and without Glucose 
Figure 3: The luciferase activity of a full length CYC1 Promoter in +/-Glucose 
solution. 
Figure 4: The Luciferase activity for the truncated CYC1 Promoter (0512) in 
+/-Glucose solution. 
Graphs: These graphs, as said above, express the activity of the full CYC J Promoter and 
the truncated CYC1 Promoter (0512). They were tested in glucose, not necessarily for the 
quantitative results, but more to ensure that the C. albicans is functioning as it normally 
would. C. albicans is naturally more active in +Glu than in -Glu. Had C. albicans not 
reacted as such, we would have known that our experiment was faulty; in other words the 
+/- Glu is a method of control. 
Discussion: 
From these results there is one very important detail to take. Although the CYC1 
Promoter is missing nearly four hundred base pairs, it is still an effective promoter. This 
is proven by the fact that it still emits luciferase activity although some of it has been 
truncated. Not only does it show luciferase activity, it reacts correctly in + and -
Glucose. 
Chapter 5 
Summary, Conclusion and Further Research 
Candida albicans is an opportunistic pathogen that is found in the gastrointestinal tracts 
of most humans. It generally takes on simple infections, however there are an increasing 
number of serious problem from C. albicans with those whose immune systems have 
been compromised. The virulence of C. albicans is yet unknown however, scientists 
speculate on the factors. C. albicans is not only being studied because of its 
pathogenicity, but because of the strides that can be made in all genetics through the 
study of yeasts. The research that is being done with C. albicans is only increasing our 
knowledge of the genetics of the organisms and so the genetics of other eukaryotic 
organisms. Scientists increase their knowledge of C. albicans by the comparison of it to 
Saccharomyces cerevisiae, which scientists know much of. However, because of the 
divergence of the two species, scientists cannot make assumptions that they are exactly 
alike. They have proven often that because of their differences, they are not. For 
example, the dual luciferase system used to detect gene expression in S. cerevisiae cannot 
be used in C. albicans because of its unusual codon strategy. Also, although the CCAAT 
binding factor is a necessity in S. cerevisiae, scientists could not assume that it would be 
the same in C. albicans, and because of this have gained new knowledge of its purpose. 
The success of the creation of the reporter plasmids provides a learning tool that 
will give an understanding of the transcriptional regulation of the genetic programs of C. 
albicans. In researching the regulatory pathways of C. albicans, scientists may be able to 
find treatments that are not toxic to humans. With the help of the Renilla luciferase 
bioluminescent reporter system, analysis of uncharacterized promoters is achievable. 
Through the successful transformation and assaying of pDM0512 we know that the CYC1 
Promoter is still effective although a portion of it has been deleted. 
Further research includes: 







• The testing of each of the plasmids using the Renilla luciferase system. 
• Then, scientists can determine the point at which the CYC1 Promoter becomes 
ineffective. 
• The relevance of the CCAAT binding factor in C. albicans may then also be 
observed; which would lead into another realm of research. 
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